Association of Pharmacological Treatments and Hospitalization and Death in Individuals With Amphetamine Use Disorders in a Swedish Nationwide Cohort of 13 965 Patients

Original research
par
Heikkinen, Milja et al

Date de publication

2022

Géographie

Sweden

Langue de la ressource

English

Texte disponible en version intégrale

Oui

Open Access / OK to Reproduce

Oui

Évalué par des pairs

Yes

L’objectif

To investigate the association between pharmacotherapies and hospitalization and mortality outcomes in persons with amphetamine or methamphetamine use disorder.

Constatations/points à retenir

In this study, lisdexamphetamine was consistently associated with improved outcomes in individuals with amphetamine use disorders, while other pharmacological treatments were not, encouraging the conduct of randomized clinical trials.

La conception ou méthodologie de recherche

Nationwide register-based cohort study (n=13,965)

Mots clés

Stimulants
Mortality
Safer supply
About PWUD
Substitution/OAT